Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1353113

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1353113

LAMEA Colorectal Cancer Screening Market Size, Share & Industry Trends Analysis Report By Type (Colonoscopy, Stool-based ), By End-user, By Country and Growth Forecast, 2023 - 2030

PUBLISHED:
PAGES: 132 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Latin America, Middle East and Africa Colorectal Cancer Screening Market would witness market growth of 8.6% CAGR during the forecast period (2023-2030).

Improvements in genomics and molecular diagnostics have transformed the detection, diagnosis, and treatment of colorectal cancer. Genetic testing can assist in identifying high-risk individuals and guiding treatment decisions based on gene mutations. Non-invasive screening techniques, including liquid biopsy, provide less invasive and more easier screening options, increasing patient participation and promoting early detection.

Advancements in medical imaging and diagnostic technologies have improved the accuracy and effectiveness of colorectal cancer screening methods, encouraging more individuals to undergo screening. The development of newer and more accurate screening methods, such as non-invasive tests like fecal immunochemical tests (FIT) and blood-based tests, has made screening more convenient and accessible to a broader population.

Due to factors including increasing colorectal cancer incidence and more patient awareness in developing nations, there is an increase in demand. The current gold standard for diagnosing and screening colorectal cancer is colonoscopies. In addition, non-invasive tests have increased screening rates due to their cost-effectiveness, accessibility, and patient preferences. This pattern is anticipated to persist throughout the forecast period, fueling the demand.

Colorectal cancer rates in Latin America are influenced by a combination of factors, including changes in lifestyle, diet, aging populations, urbanization, and limited access to healthcare. As countries in Latin America experience urbanization and economic development, there is a shift towards more sedentary lifestyles and diets rich in processed foods, red meat, and sugary beverages. The region's well established healthcare sector and the rising cancer cases are anticipated to contribute to the growth of regional market.

The Brazil market dominated the LAMEA Colorectal Cancer Screening Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $317.3 million by 2030. The Argentina market is estimated to grow at a CAGR of 9.1% during (2023 - 2030). Additionally, The UAE market would exhibit a CAGR of 8.3% during (2023 - 2030).

Based on Type, the market is segmented into Colonoscopy, Stool-based (Fecal Immunochemical Test (FIT), Fecal Occult Blood Test (FOBT), and Stool-DNA Test), and Others. Based on End-user, the market is segmented into Government, Energy, Defense, Agriculture & Forestry, Media & Entertainment, Civil Engineering & Archaeology, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novigenix SA, Eiken Chemical Co., Ltd., Clinical Genomics Pathology, Inc., Exact Sciences Corporation, Epigenomics AG, BioMerieux S.A., Olympus Corporation, Sysmex Corporation, Fujifilm Holdings Corporation, and Siemens Healthineers AG (Siemens AG)

Scope of the Study

Market Segments covered in the Report:

By Type

  • Colonoscopy
  • Stool-based
    • Fecal Immunochemical Test (FIT)
    • Fecal Occult Blood Test (FOBT)
    • Stool-DNA Test
  • Others

By End-user

  • Hospitals & Clinics
  • Clinical Laboratories
  • Diagnostic Imaging Centres
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • Novigenix SA
  • Eiken Chemical Co., Ltd.
  • Clinical Genomics Pathology, Inc.
  • Exact Sciences Corporation
  • Epigenomics AG
  • BioMerieux S.A.
  • Olympus Corporation
  • Sysmex Corporation
  • Fujifilm Holdings Corporation
  • Siemens Healthineers AG (Siemens AG)

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Colorectal Cancer Screening Market, by Type
    • 1.4.2 LAMEA Colorectal Cancer Screening Market, by End-user
    • 1.4.3 LAMEA Colorectal Cancer Screening Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints

Chapter 4. Competition Analysis - Global

  • 4.1 KBV Cardinal Matrix
  • 4.2 Recent Industry Wide Strategic Developments
    • 4.2.1 Partnerships, Collaborations and Agreements
    • 4.2.2 Product Launches and Product Expansions
    • 4.2.3 Acquisition and Mergers
    • 4.2.4 Geographical Expansions
  • 4.3 Top Winning Strategies
    • 4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
    • 4.3.2 Key Strategic Move: (Mergers & Acquisition: 2019, Jul - 2022, Dec) Leading Players
  • 4.4 Porter's Five Forces Analysis

Chapter 5. LAMEA Colorectal Cancer Screening Market by Type

  • 5.1 LAMEA Colonoscopy Market by Country
  • 5.2 LAMEA Stool-based Market by Country
  • 5.3 LAMEA Colorectal Cancer Screening Market by Stool-based Type
    • 5.3.1 LAMEA Fecal Immunochemical Test (FIT) Market by Country
    • 5.3.2 LAMEA Fecal Occult Blood Test (FOBT) Market by Country
    • 5.3.3 LAMEA Stool-DNA Test Market by Country
  • 5.4 LAMEA Others Market by Country

Chapter 6. LAMEA Colorectal Cancer Screening Market by End-user

  • 6.1 LAMEA Hospitals & Clinics Market by Country
  • 6.2 LAMEA Clinical Laboratories Market by Country
  • 6.3 LAMEA Diagnostic Imaging Centres Market by Country
  • 6.4 LAMEA Others Market by Country

Chapter 7. LAMEA Colorectal Cancer Screening Market by Country

  • 7.1 Brazil Colorectal Cancer Screening Market
    • 7.1.1 Brazil Colorectal Cancer Screening Market by Type
      • 7.1.1.1 Brazil Colorectal Cancer Screening Market by Stool-based Type
    • 7.1.2 Brazil Colorectal Cancer Screening Market by End-user
  • 7.2 Argentina Colorectal Cancer Screening Market
    • 7.2.1 Argentina Colorectal Cancer Screening Market by Type
      • 7.2.1.1 Argentina Colorectal Cancer Screening Market by Stool-based Type
    • 7.2.2 Argentina Colorectal Cancer Screening Market by End-user
  • 7.3 UAE Colorectal Cancer Screening Market
    • 7.3.1 UAE Colorectal Cancer Screening Market by Type
      • 7.3.1.1 UAE Colorectal Cancer Screening Market by Stool-based Type
    • 7.3.2 UAE Colorectal Cancer Screening Market by End-user
  • 7.4 Saudi Arabia Colorectal Cancer Screening Market
    • 7.4.1 Saudi Arabia Colorectal Cancer Screening Market by Type
      • 7.4.1.1 Saudi Arabia Colorectal Cancer Screening Market by Stool-based Type
    • 7.4.2 Saudi Arabia Colorectal Cancer Screening Market by End-user
  • 7.5 South Africa Colorectal Cancer Screening Market
    • 7.5.1 South Africa Colorectal Cancer Screening Market by Type
      • 7.5.1.1 South Africa Colorectal Cancer Screening Market by Stool-based Type
    • 7.5.2 South Africa Colorectal Cancer Screening Market by End-user
  • 7.6 Nigeria Colorectal Cancer Screening Market
    • 7.6.1 Nigeria Colorectal Cancer Screening Market by Type
      • 7.6.1.1 Nigeria Colorectal Cancer Screening Market by Stool-based Type
    • 7.6.2 Nigeria Colorectal Cancer Screening Market by End-user
  • 7.7 Rest of LAMEA Colorectal Cancer Screening Market
    • 7.7.1 Rest of LAMEA Colorectal Cancer Screening Market by Type
      • 7.7.1.1 Rest of LAMEA Colorectal Cancer Screening Market by Stool-based Type
    • 7.7.2 Rest of LAMEA Colorectal Cancer Screening Market by End-user

Chapter 8. Company Profiles

  • 8.1 Novigenix SA
    • 8.1.1 Company Overview
    • 8.1.2 SWOT Analysis
  • 8.2 Eiken Chemical Co., Ltd.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Research & Development Expenses
  • 8.3 Clinical Genomics Pathology, Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Recent strategies and developments:
      • 8.3.2.1 Partnerships, Collaborations, and Agreements:
    • 8.3.3 SWOT Analysis
  • 8.4 Exact Sciences Corporation
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Regional Analysis
    • 8.4.4 Research & Development Expenses
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Acquisition and Mergers:
    • 8.4.6 SWOT Analysis
  • 8.5 Epigenomics AG
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Regional Analysis
    • 8.5.4 Research & Development Expenses
    • 8.5.5 SWOT Analysis
  • 8.6 BioMerieux S.A.
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Segmental and Regional Analysis
    • 8.6.4 Research & Development Expenses
    • 8.6.5 Recent strategies and developments:
      • 8.6.5.1 Partnerships, Collaborations, and Agreements:
      • 8.6.5.2 Acquisition and Mergers:
    • 8.6.6 SWOT Analysis
  • 8.7 Olympus Corporation
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expenses
    • 8.7.5 Recent strategies and developments:
      • 8.7.5.1 Partnerships, Collaborations, and Agreements:
      • 8.7.5.2 Product Launches and Product Expansions:
      • 8.7.5.3 Acquisition and Mergers:
    • 8.7.6 SWOT Analysis
  • 8.8 Sysmex Corporation
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Regional Analysis
    • 8.8.4 Research & Development Expense
    • 8.8.5 SWOT Analysis
  • 8.9 Siemens Healthineers AG (Siemens AG)
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental and Regional Analysis
    • 8.9.4 Research & Development Expense
      • 8.9.4.1 Acquisition and Mergers:
    • 8.9.5 SWOT Analysis
  • 8.10. Fujifilm Holdings Corporation
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Segmental and Regional Analysis
    • 8.10.4 Research & Development Expenses
    • 8.10.5 Recent strategies and developments:
      • 8.10.5.1 Partnerships, Collaborations, and Agreements:
      • 8.10.5.2 Product Launches and Product Expansions:
      • 8.10.5.3 Geographical Expansions:
    • 8.10.6 SWOT Analysis

LIST OF TABLES

  • TABLE 1 LAMEA Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 2 LAMEA Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Colorectal Cancer Screening Market
  • TABLE 4 Product Launches And Product Expansions- Colorectal Cancer Screening Market
  • TABLE 5 Acquisition and Mergers- Colorectal Cancer Screening Market
  • TABLE 6 Geographical Expansions- Colorectal Cancer Screening Market
  • TABLE 7 LAMEA Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 8 LAMEA Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 9 LAMEA Colonoscopy Market by Country, 2019 - 2022, USD Million
  • TABLE 10 LAMEA Colonoscopy Market by Country, 2023 - 2030, USD Million
  • TABLE 11 LAMEA Stool-based Market by Country, 2019 - 2022, USD Million
  • TABLE 12 LAMEA Stool-based Market by Country, 2023 - 2030, USD Million
  • TABLE 13 LAMEA Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 14 LAMEA Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 15 LAMEA Fecal Immunochemical Test (FIT) Market by Country, 2019 - 2022, USD Million
  • TABLE 16 LAMEA Fecal Immunochemical Test (FIT) Market by Country, 2023 - 2030, USD Million
  • TABLE 17 LAMEA Fecal Occult Blood Test (FOBT) Market by Country, 2019 - 2022, USD Million
  • TABLE 18 LAMEA Fecal Occult Blood Test (FOBT) Market by Country, 2023 - 2030, USD Million
  • TABLE 19 LAMEA Stool-DNA Test Market by Country, 2019 - 2022, USD Million
  • TABLE 20 LAMEA Stool-DNA Test Market by Country, 2023 - 2030, USD Million
  • TABLE 21 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 22 LAMEA Others Market by Country, 2023 - 2030, USD Million
  • TABLE 23 LAMEA Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 24 LAMEA Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 25 LAMEA Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
  • TABLE 26 LAMEA Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
  • TABLE 27 LAMEA Clinical Laboratories Market by Country, 2019 - 2022, USD Million
  • TABLE 28 LAMEA Clinical Laboratories Market by Country, 2023 - 2030, USD Million
  • TABLE 29 LAMEA Diagnostic Imaging Centres Market by Country, 2019 - 2022, USD Million
  • TABLE 30 LAMEA Diagnostic Imaging Centres Market by Country, 2023 - 2030, USD Million
  • TABLE 31 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 32 LAMEA Others Market by Country, 2023 - 2030, USD Million
  • TABLE 33 LAMEA Colorectal Cancer Screening Market by Country, 2019 - 2022, USD Million
  • TABLE 34 LAMEA Colorectal Cancer Screening Market by Country, 2023 - 2030, USD Million
  • TABLE 35 Brazil Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 36 Brazil Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 37 Brazil Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 38 Brazil Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 39 Brazil Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 40 Brazil Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 41 Brazil Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 42 Brazil Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 43 Argentina Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 44 Argentina Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 45 Argentina Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 46 Argentina Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 47 Argentina Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 48 Argentina Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 49 Argentina Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 50 Argentina Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 51 UAE Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 52 UAE Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 53 UAE Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 54 UAE Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 55 UAE Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 56 UAE Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 57 UAE Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 58 UAE Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 59 Saudi Arabia Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 60 Saudi Arabia Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 61 Saudi Arabia Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 62 Saudi Arabia Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 63 Saudi Arabia Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 64 Saudi Arabia Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 65 Saudi Arabia Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 66 Saudi Arabia Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 67 South Africa Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 68 South Africa Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 69 South Africa Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 70 South Africa Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 71 South Africa Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 72 South Africa Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 73 South Africa Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 74 South Africa Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 75 Nigeria Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 76 Nigeria Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 77 Nigeria Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 78 Nigeria Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 79 Nigeria Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 80 Nigeria Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 81 Nigeria Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 82 Nigeria Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 83 Rest of LAMEA Colorectal Cancer Screening Market, 2019 - 2022, USD Million
  • TABLE 84 Rest of LAMEA Colorectal Cancer Screening Market, 2023 - 2030, USD Million
  • TABLE 85 Rest of LAMEA Colorectal Cancer Screening Market by Type, 2019 - 2022, USD Million
  • TABLE 86 Rest of LAMEA Colorectal Cancer Screening Market by Type, 2023 - 2030, USD Million
  • TABLE 87 Rest of LAMEA Colorectal Cancer Screening Market by Stool-based Type, 2019 - 2022, USD Million
  • TABLE 88 Rest of LAMEA Colorectal Cancer Screening Market by Stool-based Type, 2023 - 2030, USD Million
  • TABLE 89 Rest of LAMEA Colorectal Cancer Screening Market by End-user, 2019 - 2022, USD Million
  • TABLE 90 Rest of LAMEA Colorectal Cancer Screening Market by End-user, 2023 - 2030, USD Million
  • TABLE 91 Key Information - Novigenix SA
  • TABLE 92 Key Information - Eiken Chemical Co., Ltd.
  • TABLE 93 Key Information - Clinical Genomics Pathology, Inc.
  • TABLE 94 Key Information - Exact Sciences Corporation
  • TABLE 95 Key Information - Epigenomics AG
  • TABLE 96 Key Information - BioMerieux S.A.
  • TABLE 97 Key Information - Olympus Corporation
  • TABLE 98 Key Information - Sysmex Corporation
  • TABLE 99 Key Information - Siemens Healthineers AG
  • TABLE 100 Key Information - Fujifilm Holdings Corporation

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 LAMEA Colorectal Cancer Screening Market, 2019 - 2030, USD Million
  • FIG 3 Key Impacting Factors Colorectal Cancer Screening Market
  • FIG 4 KBV Cardinal Matrix
  • FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
  • FIG 6 Key Strategic Move: (Mergers & Acquisition: 2019, Jul - 2022, Dec) Leading Players
  • FIG 7 Porter's Five Forces Analysis - Colorectal Cancer Screening Market
  • FIG 8 LAMEA Colorectal Cancer Screening Market share by Type, 2022
  • FIG 9 LAMEA Colorectal Cancer Screening Market share by Type, 2030
  • FIG 10 LAMEA Colorectal Cancer Screening Market by Type, 2019 - 2030, USD Million
  • FIG 11 LAMEA Colorectal Cancer Screening Market share by End-user, 2022
  • FIG 12 LAMEA Colorectal Cancer Screening Market share by End-user, 2030
  • FIG 13 LAMEA Colorectal Cancer Screening Market by End-user, 2019 - 2030, USD Million
  • FIG 14 LAMEA Colorectal Cancer Screening Market share by Country, 2022
  • FIG 15 LAMEA Colorectal Cancer Screening Market share by Country, 2030
  • FIG 16 LAMEA Colorectal Cancer Screening Market by Country, 2019 - 2030, USD Million
  • FIG 17 SWOT Analysis: Novigenix SA
  • FIG 18 SWOT Analysis: Clinical Genomics Pathology, Inc.
  • FIG 19 SWOT Analysis: Exact Sciences Corporation
  • FIG 20 SWOT Analysis: Epigenomics AG
  • FIG 21 SWOT Analysis: BioMerieux S.A.
  • FIG 22 Recent strategies and developments: Olympus Corporation
  • FIG 23 SWOT Analysis: Olympus Corporation
  • FIG 24 SWOT Analysis: Sysmex Corporation
  • FIG 25 SWOT Analysis: Siemens Healthineers AG
  • FIG 26 Recent strategies and developments: Fujifilm Holdings Corporation
  • FIG 27 SWOT Analysis: Fujifilm Holdings Corporation
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!